As of 10.01.2020, our company has been authorized to obtain human medicinal products from abroad, which are not licensed and / or licensed in our country but are not available for various reasons.
In this context, our infrastructure studies on drug supply from abroad are ongoing, and details of the subject will be announced to our valuable stakeholders on our website as soon as possible.
